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The Mycobacterium tuberculosis dosR gene (Rv3133c) is part of an operon, Rv3134c-Rv3132c, and encodes a
response regulator that has been shown to be upregulated by hypoxia and other in vitro stress conditions and
may be important for bacterial survival within granulomatous lesions found in tuberculosis. DosR is activated
in response to hypoxia and nitric oxide by DosS (Rv3132c) or DosT (Rv2027c). We compared the virulence
levels of an M. tuberculosis dosR-dosS deletion mutant (dosR-dosS [dosR-S]), a dosR-complemented strain,
and wild-type H37Rv in rabbits, guinea pigs, and mice infected by the aerosol route and in a mouse hollow-fiber
model that may mimic in vivo granulomatous conditions. In the mouse and the guinea pig models, the dosR-S
mutant exhibited a growth defect. In the rabbit, the dosR-S mutant did not replicate more than the wild type.
In the hollow-fiber model, the mutant phenotype was not different from that of the wild-type strain. Our
analyses reveal that the dosR and dosS genes are required for full virulence and that there may be differences
in the patterns of attenuation of this mutant between the animal models studied.
Tuberculosis control is complicated by the ability of Myco-
bacterium tuberculosis to persist in human tissues despite host
immune containment. Low oxygen tension occurring in gran-
ulomatous lesions and/or nitric oxide (NO) exposure due to
macrophage activation may be an important factor in promot-
ing mycobacterial persistence. The M. tuberculosis dormancy
survival regulator (dosR [devR]) (3) encoded by Rv3133c is a
member of a two-component regulatory system that is induced
by hypoxia and NO exposure and may be an important tran-
scriptional regulator during persistence. The sensor compo-
nent is encoded by dosS (Rv3132c), although DosR can also be
activated by an alternate sensor encoded by dosT (Rv2027c).
No animal model perfectly mimics the spectrum of human
tuberculosis (4). The mouse model is inexpensive, well char-
acterized, reproducible, and capable of demonstrating the ster-
ilizing activity of rifampin and pyrazinamide on persisting tu-
bercle bacilli (16). However, mouse granulomas are diffuse
cellular aggregates (28) that are histologically distinct from
human caseous granulomas. Guinea pigs and rabbits reproduc-
ibly form classical-appearing caseous granulomas (37), which,
in rabbits, may subsequently liquefy and cavitate (8). While
precise oxygen tension measurements have not been deter-
mined for tuberculous lung lesions in these three species, there
is recent evidence that the granuloma-like lesions in mouse
lungs lack tissue hypoxia (2, 36). In contrast, oxygen levels may
be more profoundly depleted within guinea pig (17) and rabbit
(38) lesions, which more closely approximate the histology of
human tuberculous lesions.
The dosR gene is induced following exposure to progressive
hypoxia in vitro (39) and might be required for M. tuberculosis
survival in the hypoxic lesions of guinea pigs or rabbits. Myco-
bacterium bovis BCG lacking dosR is attenuated under hypoxic
conditions in vitro (3). However, dosR is also induced in re-
sponse to NO (29, 39), which is likely a major factor in M.
tuberculosis growth containment in the mouse. The transcrip-
tional response of bacteria to either hypoxia or NO appears to
have significant, if not complete, overlap (4, 33). Therefore, all
three animal models have the potential to be informative re-
garding the importance of the DosR regulon during M. tuber-
culosis infection.
Previously reported studies using the mouse (26, 31) and
guinea pig (21) models have produced conflicting results re-
garding the virulence of M. tuberculosis lacking dosR. Parish et
al. previously found that SCID mice infected intravenously
with a dosR deletion mutant died more rapidly than mice
infected with wild-type bacteria (26). Mutant-infected DBA/2
mice also had higher organ bacterial burdens. Rustad et al., on
the other hand, observed similar levels of growth of H37Rv
and the dosR mutant in organs from three mouse strains (31).
However, Malhotra et al. found that a mutant expressing a
truncated DosR protein showed reduced pathology and spleen
bacillary burdens in subcutaneously infected guinea pigs (21).
Given the conflicting phenotypes observed for different dosR
mutants in mice and guinea pigs, we sought to test directly the
role of dosR in M. tuberculosis virulence in different animal
models with various degrees of resistance to M. tuberculosis
infection. Using the resources of the Tuberculosis Animal Re-
search and Gene Evaluation Taskforce (http://webhost.nts.jhu
.edu/target/), we evaluated bacterial load over time, mortality,
* Corresponding author. Mailing address: Center for Tuberculosis
Research, 1550 Orleans Street, Room 103, Baltimore, MD 21231.
Phone: (410) 502-8236. Fax: (410) 614-8173. E-mail: pconvers@jhsph
.edu.
† Supplemental material for this article may be found at http://iai
.asm.org/.
‡ Present address: Department of Medicine, Division of Infectious
Diseases, Vanderbilt University School of Medicine, Nashville, TN.
 Published ahead of print on 22 December 2008.
1230
 at W
ELCH M
EDICAL LIBRARY - John Hopkins U on M
ay 4, 2009 
iai.asm
.org
D
ow
nloaded from
 
gross pathology, and histopathology of mice, guinea pigs, and
rabbits infected by aerosol with the same M. tuberculosis
H37Rv strain, a deletion mutant lacking dosR and dosS
(dosR-S) in which a single deletion event resulted in the
deletion of adjacent genes, and a dosR-complemented strain
(Comp). We also tested these strains in a mouse hollow-fiber
(HF) model of tuberculosis (12), which was recently shown to
develop tissue hypoxia (14). Because the dosR strain was
reported to be hypervirulent in the mouse model (26) and
rabbits are relatively resistant to infection with wild-type M.
tuberculosis, hypervirulence associated with dosR deficiency
should be readily apparent in the rabbit model. However, our
results consistently show an attenuated phenotype for the
dosR-S deletion mutant in the aerosol models but also phe-
notypic differences between the various models.
MATERIALS AND METHODS
Mycobacteria and culture conditions. Subcultures of H37Rv, H37Rv:dosR::kan,
and Comp were prepared from frozen stocks (obtained from D. Sherman, University
of Washington) in Middlebrook 7H9 broth with 0.1% Tween 80 and 10% oleic
acid-albumin-dextrose-catalase (Becton Dickinson) or on Middlebrook 7H10 plates
at 37°C, as described previously (34). When needed, kanamycin (20 g ml1) and
hygromycin (50 g ml1) were added. All strains were passaged twice in BALB/c
mice.
Bacterial strains. The targeted disruption of dosR was performed as described
previously (34).
dosR complementation. The dosR upstream region was PCR amplified using
specific primers (see Table S1 in the supplemental material). The amplicon was
cloned into the PvuII and Asp718 sites of a pMH108-based integrating vector (9)
to generate the complementation vector pDosR. This construct was integrated
into H37Rv:dosR by electroporation (29). This strain, H37Rv:dosR::dosR, is
here referred to as Comp.
Progressive hypoxia model of infection and reverse transcription (RT)-PCR
analysis. The progressive hypoxia model was performed as described previously
(40). Methylene blue decolorization served as a visual indicator of oxygen levels
corresponding to nonreplicating persistence stage 2 (40). Samples were collected
from parallel cultures 3 days prior to the methylene blue color change. RNA was
recovered from samples as previously described (34), confirmed to be DNA free,
and stored at 80°C. cDNA was prepared using iQ Sybr green supermix (Bio-
Rad) according to the manufacturer’s recommendations and amplified by quan-
titative PCR using gene-specific primers (see Table S1 in the supplemental
material). The cycle threshold value (CT) obtained for each gene of interest was
normalized with that of sigA (23) in order to obtain a normalized CT [normalized
CT  (sigA CT)  (CT for gene of interest)]. Each value represents the average
of data from three technical replicates.
Mice and infection with M. tuberculosis. Animal protocols were approved by
the Johns Hopkins University Animal Care and Use Committee. Six-week-old
female C57BL/6 and BALB/c mice (Charles River, Wilmington, MA) were
infected with M. tuberculosis H37Rv, H37Rv dosR-S, or Comp using the Glas-
Col (Terre Haute, IN) inhalation exposure system. CFU counts of the inoculum
were determined. On day 1 after infection, three to five mice from each group
were sacrificed, and the number of implanted CFU was determined. At regular
time points thereafter, five mice from each group were sacrificed for lung and
spleen CFU counts. Typically, half of each lung was used for CFU counts, and
the other half was placed into formalin for histopathology. Additional mice in
each group were monitored daily for time to death.
Guinea pigs and infection. Outbred Hartley guinea pigs (Charles River, Wil-
mington, MA) were maintained according to procedures of the Texas A&M
University Laboratory Animal Care Committee. Guinea pigs were infected with
approximately 20 CFU of M. tuberculosis H37Rv, H37Rv dosR-S, or Comp in
a Madison aerosol chamber, as described previously (41). Five animals from each
group were sacrificed at 2 and 6 weeks after infection. The right lower lung lobe
and a portion of the spleen were homogenized in separate Teflon-glass homog-
enizers and plated for CFU enumeration. Twenty-four hours prior to sacrifice,
each guinea pig was injected with 100 tuberculin units (2 g) of purified protein
derivative (PPD) (Mycos, Loveland, CO) into a shaved area on the flank. Indu-
ration was measured 24 h later, and mean diameter was recorded.
Rabbits and infection. Female New Zealand White rabbits (Covance Research
Products, Denver, PA) were maintained according to protocols approved by the
Johns Hopkins University Animal Care and Use Committee, George Washing-
ton University, and the U.S. Army Medical Research Institute of Infectious
Diseases (6). Infection was performed as described previously (22). For each
rabbit, the number of viable bacilli inhaled was calculated based on the volume
of inhaled air during exposure and the number of CFU cultured from the
impinger samples per milliliter. Two days prior to sacrifice, Old Tuberculin
concentrate (Wyeth Lederle, Pearl River, NY) was injected intradermally, and
induration was measured as previously described (22). At day 1 and at 5 weeks
(experiment 1) or at 8 weeks (experiment 2) after infection, the rabbits were
sacrificed, and the number of grossly visible primary tubercles in the entire lungs
was counted by Lurie’s tubercle count method (7, 18). The right upper lobe was
homogenized for determination of bacterial burden.
HF assay. Infection with M. tuberculosis, the deletion mutant, or Comp strains
was achieved using 6- to 8-week-old female hairless immunocompetent SKH1
mice (Charles River) using the HF encapsulation-implantation technique as
described previously (12). For determinations of CFU counts, HFs were recov-
ered from mice at the time of sacrifice (days 1, 7, 14, 21, 28, and 56). Log-
transformed CFU values were used to calculate averages and standard errors.
Pathology and histopathology. Lungs and spleens (as well as guinea pig liver)
were excised from all animals and stored in 10% formalin, embedded, and
stained with hematoxylin and eosin for pathological analysis. In order to deter-
mine the extent of granulomatous tissue, the area of guinea pig lesions was
measured using Image-Pro Plus 5.1 software.
RESULTS
RT-PCR analysis reveals the absence of both dosR and dosS
from the dosR strain. In vitro growth in a variety of media
was measured to assess the fitnesses of the mutant strains.
We determined that all four strains grew comparably in vitro
(see Fig. S1 in the supplemental material). RT-PCR was
used to verify the presence of dosR and the other compo-
nents of its operon in the three strains, as well as in another
dosR-complemented strain with a different promoter con-
struct, after exposure to hypoxic stress, a condition known to
induce dosR expression (39). RT-PCR revealed that all four
strains carried the upstream gene Rv3134c (Fig. 1). As ex-
pected, Rv3133c (dosR) expression was absent only in the
FIG. 1. Expression of components of the dosR operon (Rv3134c-
Rv3132c). Four strains, the H37Rv wild-type (WT) parental strain
(solid bars), a putative dosR deletion mutant, and two dosR-comple-
mented strains with native and mycobacterial optimal promoters
(MOP), were subjected to hypoxic stress (see Materials and Methods)
to enhance expression. Extracted DNA-free RNA was subjected to
RT, and the cDNA was subjected to 40 cycles of quantitative PCR.
Expression was normalized to that of the housekeeping gene sigA (20
cycles), such that enhanced expression (fewer cycles to detection [CT])
is shown as being positive and those with undetectable product are
shown as being negative. The deletion mutant has no detectable dosR
or dosS, while the complemented strains have restored dosR but not
dosS.
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mutant. However, only the wild-type parent and, unexpect-
edly, neither complemented strain or the deletion mutant
expressed Rv3134c (dosS). All four strains carried dosT,
which shares many, if not all, of the functions of DosS (15,
32; data not shown). Therefore, the mutant will be described
as dosR-S. The complemented strain has a partial restora-
tion of the Rv3134c-Rv3132c operon, as it expresses dosR
but not dosS.
Rabbit infection with the dosR-S mutant reveals defective
survival. H37Rv dosR-S and wild-type parent strains were
tested in a 5- and 8-week rabbit aerosol infection model. In the
first experiment, both the right upper lobe CFU counts 1 day
after aerosol infection and the calculated average inhaled dose
were similar for both groups (Fig. 2A). The difference between
these two values is the same as that described previously by
Lurie in the 1950s (18, 19). The weights, weight gain, and
tuberculin skin test results did not differ between groups
over the course of the 5-week experiment (Table 1). At week
5, mutant-infected rabbits had slightly smaller right upper
lung lobes (P  0.05), consistent with less inflammation, and
a trend toward lower total lung weight (P  0.08). However,
the total right upper lung lobe CFUs were not significantly
FIG. 2. Comparison of M. tuberculosis H37Rv:dosR-S and wild-type H37Rv in rabbits after aerosol infection. In a first 5-week experiment (A),
the bacterial burden was comparable at 5 weeks, while in a second 8-week experiment (B), there was a significantly (P  0.0312 by Wilcoxon test)
lower bacillary burden at 8 weeks. The average inhaled doses in each experiment were not significantly different between bacterial strains. The
differences were also not significant with regard to the number of bacteria implanted (1.91  0.04 log10 CFU for the wild type and 1.66  0.097
log10 CFU for the dosR-S strain) in the 5-week experiment (A) and were also not significant in the 8-week experiment (B), in which the doses
implanted at day 1 were calculated (calc*) based on the differences between inhaled and implanted doses in the first experiment, which are similar
to those reported previously in the literature for the rabbit model (8, 18). For a detailed explanation, see the text. Histopathological analysis of
rabbit lungs 5 weeks after infection with M. tuberculosis H37Rv (C and E) shows a well-organized primary granulomatous lesion with dark
lymphocytes surrounding pale epithelioid macrophages capable of killing tubercle bacilli. In contrast, with the dosR-S deletion mutant (D and
F), the lesions were fewer and smaller. Magnifications, 20 (C and D) and 200 (E and F).
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different between the mutant- and wild-type-infected rabbits
(Fig. 2A).
In order to assess the possibility of delayed attenuation, a
second experiment in which rabbits were sacrificed 8 weeks
after aerosol infection was performed (Table 1). At this time
point, there was a trend toward lower spleen weights in animals
infected with the dosR-S strain (P  0.06). The right upper
lobe bacillary burden was lower for the mutant than for the
wild type (P 0.03), consistent with a lower inoculum but also,
possibly, with reduced virulence for the mutant (Fig. 2B). Al-
though the complemented strain was also tested using rabbits,
the inhaled dose was significantly lower than that for the other
two strains and could not be evaluated. Pathology samples
revealed that wild-type-infected lesions appeared more in-
tense, more numerous, and better organized than mutant-in-
fected lesions in the animals sacrificed at 5 weeks (Fig. 2C to F).
We conclude that in the rabbit model, the dosR-S mutant
induced somewhat less inflammation, was not hypervirulent,
and may even have defective survival following the onset of
tuberculin reactivity.
Mice resist multiplication of the dosR-S strain more effec-
tively than wild-type M. tuberculosis. In C57BL/6 mice infected
with all three strains, the wild-type strain multiplied normally,
while the mutant and Comp strains multiplied more slowly (Fig.
3A and B). By week 4, the CFU counts of the mutant and Comp
strains were lower (P	 0.001) than those of the wild type in both
lungs and spleen. Given the failure of the Comp strain to restore
the wild-type phenotype once again even after matching implan-
tation, CFU assessment of this strain was discontinued after week
4. Interestingly, the difference in CFU between the mutant and
wild-type strains narrowed between weeks 4 and 16 but remained
unchanged at week 24. We conclude that the dosR-S mutant
does not multiply as well as the wild type in mouse tissues. With
matching implantation doses, larger lesions and the pathological
involvement of a greater proportion of the lung were observed 2
months after infection in mice infected with the wild-type strain
(Fig. 3C) relative to mice infected with the mutant strain (Fig.
3D).
The dosR-S mutant is attenuated in guinea pig before
onset of tuberculin reactivity. Guinea pigs were aerosol in-
fected in a Madison chamber calculated to deliver 20 (1.3
log10) CFU/lung of M. tuberculosis H37Rv, the dosR-S mu-
tant, or the dosR complemented strain. By day 14 after infec-
tion, growth of nearly 2 log10 CFU/week was found, as ex-
pected, in the lungs infected with the wild-type strain to 105
CFU, while fewer than 102 CFU and 103 CFU were recovered
from dosR-S strain-infected lungs and complement-infected
lungs, respectively (Fig. 4A). At this time point, spleen CFU
counts for the complemented strain nearly matched those of
the wild-type strain (Fig. 4A). By week 6, wild-type-infected
lung and spleen CFU counts were higher than the correspond-
ing CFU counts at day 14. Although organ CFU counts for the
mutant and complemented strains were also higher than their
respective day 14 values, they remained low relative to the
corresponding organ CFU for the wild type at 6 weeks. Skin
test responses at week 6 were comparable for wild-type- and
complement-infected guinea pigs and significantly greater (P	
0.025) than that of the mutant-infected animals (Fig. 4B). These
results are consistent with a growth defect for the dosR-S
mutant in guinea pig organs but also with a reduced virulence
of the complemented strain in this model.
Two weeks after infection, relatively small tubercles could be
seen in wild-type-infected guinea pig lungs (Fig. 5A), with early
granulomatous lesions seen at higher magnifications (Fig. 5G).
Conversely, at the same time point, there was little inflamma-
tion in the lungs of guinea pigs infected with either the mutant
(Fig. 5B) or complemented (Fig. 5C) strain, with only a few
scattered inflammatory cells (Fig. 5H). By 6 weeks, there was
massive inflammation in wild-type-infected lungs (Fig. 5D),
and lesions revealed extensive central necrosis (Fig. 5I). In-
flammation appeared to be reduced in dosR-S strain-infected
lungs (Fig. 5E), with a lack of mature granuloma formation
and minimal necrosis (Fig. 5J) relative to lesions in comple-
ment-infected animals (Fig. 5F), consistent with a reduced
virulence of the dosR-S mutant.
Finally, we attempted to quantify both the lesion number
and the percentage of the lung sections occupied by granulo-
mas for each strain. These data are shown in Table S2 in the
supplemental material. In general, lesion number and percent-
age of lung occupied by granulomas correlated very well, with
the exception of one mutant-infected animal and one comple-
ment-infected animal. A qualitative analysis of these excep-
tions indicated that their granulomas were poorly formed,
abortive, or immature lesions that in no way resembled the
lesions seen in the wild-type-infected animals.
In the mouse HF model of latent tuberculosis, the dosR and
dosS genes are not essential for M. tuberculosis persistence. The
mouse HF model facilitates the establishment of M. tuber-
TABLE 1. Differences between rabbits infected with M. tuberculosis H37Rv or the dosR-S strain at 5 weeks and those infected at
8 weeks after infection in two consecutive experiments
Parameter
Valueb
Wk 5 Wk 8
H37Rv H37Rv:dosR-S H37Rv H37Rv:dosR-S
Tuberculin skin test (mm3) 
median (range) 62 (7–403) 219 (0–706) 61 (0–4752) 203 (0–960)
Mean hilar lymph node wt (mg)  SD 423  102 336  52 96  20 92  18
Mean total lung wt (g)  SD 13.8  1.2 11.2  0.4 13.2  0.8 13.5  0.3
Mean right upper lobe wt (g)  SD 1.5  0.2 1.2  0.1a 1.0  0.06 1.1  0.04
Mean spleen wt (g)  SD 2.2  0.4 1.6  0.1 1.7  0.2 1.3  0.1
Avg tubercle count  SD 187  17 148  44 113  23 27  12a
Avg tubercle diam  SD 1.5  0.1 1.0  0.1a 1.4  0.2 1.0  0.1
a P  0.05.
b Values in boldface type are statistically significant.
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culosis persistence in an extracellular, paucibacillary state
analogous to that for solid caseous necrosis. M. tuberculosis
cells encapsulated within semidiffusible HFs implanted in
mice demonstrate a phenotype characterized by stationary-
state CFU, decreased metabolic activity, and increased sus-
ceptibility to the sterilizing drug rifampin compared to the
bactericidal drug isoniazid (12). Recently, the hypoxia-spe-
cific marker pimonidazole was shown to stain the perifiber
granulomatous tissue in this model in a bacillary dose-de-
pendent manner (14), suggesting that hypoxia may play a
role in intrafiber bacillary growth containment.
Mice gained weight equivalently in the three groups over 56
days (not shown). Spleen weights increased in mice implanted
with fibers containing Comp over the first 14 days, but all mice
had similar spleen weights by day 56 (not shown).
Intrafiber CFU counts remained stable over 56 days. On day
FIG. 3. Growth after well-matched implantation of wild-type H37Rv, dosR-S, and Comp strains. In spite of comparable implantation levels,
the dosR-S mutant did not multiply as well in the lungs (A) or the spleen (B) as the wild type. The dosR-S mutant complemented with the
mycobacterial optimal promoter (Comp) does not grow as well in the lungs or spleen as the wild-type strain even with comparable levels of
implantation (2.71  0.19 log10 CFU for H37Rv, 3.11  0.11 log10 CFU for the dosR-S strain, and 2.98  0.20 log10 CFU for Comp) over the
first 28 days. (C and D) Histopathology of lungs of C57BL/6 mice infected with M. tuberculosis (M. tb) H37Rv (C) or a dosR-S deletion mutant
(D) 2 months after infection. At 2 months, the lesions were large and dense in wild-type-infected mouse lungs compared to the scattered lesions
in dosR-S-infected mouse lungs, in which more normal lung tissue was preserved. No lesions showed evidence of necrosis. Magnification, 20.
FIG. 4. Guinea pigs resist multiplication of M. tuberculosis (M. tb) cells lacking dosR and dosS. (A) After infection with approximately 1.3 log10
CFU, the complemented strain (Comp) initially multiplied at an intermediate level between H37Rv wild-type and dosR-S mutant bacillus levels
before the onset of tuberculin reactivity, but by week 6, the growth of this strain declined to the same level as that seen for the dosR-S mutant
bacilli. Lungs are shown with solid lines, and spleens are shown with dashed lines. (B) Reactivity to tuberculin (PPD). The wild-type and
complemented (Comp) strains elicit a stronger (P 	 0.025 by one-way analysis of variance) mean delayed-type hypersensitivity response to PPD
than does the dosR-S mutant (horizontal stripes).
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1 after HF implantation, counts varied between 300 and 1,000
CFU per fiber for each of the three groups. As observed
previously (12, 14), numbers of wild-type CFU remained rel-
atively constant throughout. Although the dosR-S strain ap-
peared to have an initial intrafiber survival defect, since CFU
decreased by 10-fold on day 14 after fiber implantation, CFU
counts at day 56 were not statistically significantly different
than those on day 1 (not shown). Interestingly, Comp did not
appear to have an intrafiber survival defect during the first 14
days after HF implantation, but CFU counts declined more
than 10-fold by day 28 and remained statistically significantly
lower than those of the other two groups at day 56 after fiber
implantation (P 	 0.05).
As observed previously (12), HFs containing wild-type M.
tuberculosis cells progressively developed thick, circumferential
inflammation in the subcutaneous tissue immediately sur-
rounding the HF. The perifiber pathologies, both grossly and
histologically (not shown), were similar in wild-type-, dosR-S
mutant-, and complement-containing fibers. Taken together,
the results for the HF model indicate that there is neither
increased virulence nor attenuation of the dosR-S strain com-
pared to the wild type.
DISCUSSION
NO, the predominant mechanism limiting bacillary growth
in mouse lungs (5, 20), and hypoxia, prevalent in the caseous
and necrotic lesions of guinea pigs (17) and rabbits (38), both
induce DosR and its regulon (33, 34, 39). Contrary to previous
studies reporting hypervirulence of a dosR-deficient mutant in
DBA/2 mice (26), our data suggest that disruption of dosR
leads to attenuation in a mouse aerosol model using the more
resistant BALB/c (data not shown) and C57BL/6 mouse
strains. Consistent with previously reported findings (21), our
FIG. 5. (A to C) Histopathology of lungs of guinea pigs infected with M. tuberculosis H37Rv, a dosR-S deletion mutant, or the mutant
complemented with dosR at 2 weeks, before the onset of tuberculin reactivity. Only a small early granulomatous, noncaseating lesion (arrow) in
the lung of a wild-type-infected guinea pig was observed at this time (A). Mutant- and complement-infected guinea pigs showed only rare
inflammatory peribronchial/periarteriolar infiltrates (arrows). (D to F) At 6 weeks, there was strong tuberculin reactivity (see Table S2 in the
supplemental material) and substantial inflammation and necrosis (arrows) in the lungs of wild-type-infected guinea pigs (D), almost none
detectable in the mutant-infected animals (E), and small, poorly organized granulomas (arrows) in the complement-infected guinea pigs (F).
Magnification, 20. (G to J) Above-described lung lesions of guinea pigs infected with H37Rv wild-type (G and I) and dosR-S (H and J) mutant
strains at higher magnifications. Caseous necrosis (arrow) is apparent in the lesions of the wild-type-infected guinea pig at 6 weeks (I), whereas
a rare lesion (J) in a dosR-S mutant-infected animal shows rather poor organization and limited necrosis (arrow). Magnification, 100.
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mutant was also attenuated in the guinea pig model. Since the
rabbit is relatively resistant to M. tuberculosis infection (8, 22),
a hypervirulent mutant should be readily apparent in this
model. However, such a phenotype was not observed in our
study, suggesting that a dosR deficiency does not lead to in-
creased virulence in vivo.
We observed the failure of the dosR-complemented strain to
restore the wild-type phenotype. This finding may be explained
by the fact that dosR appears to be the second gene in an
operon: Rv3134c, Rv3133c (devR, or dosR), and Rv3132c
(devS, or dosS). In such a location, disruption of dosR may have
a polar effect on the expression of the distal gene dosS. Indeed,
dosS expression was not restored in the complement strain,
suggesting a potential role for dosS in the observed attenuated
phenotype of this strain. The possibility of polar effects occur-
ring downstream of mutations in this operon was also sug-
gested in a recent study in which an Rv3134c transposon mu-
tant was attenuated in different models of hypoxia (14). Given
the lack of complete data on complemented dosR strains in
previous reports, the possibility remains that complementation
in trans may result in inappropriately regulated expression and
a reduction of viability (35).
The discrepancy between our findings, those of Rustad et
al. (31), and those of Parish et al. (26) might be explained by
mismatched implantation in the latter study, since lung CFU
counts at day 1 were not reported, and the difference be-
tween mutant and wild-type groups in lung CFU counts at
day 15 became progressively smaller through day 60. In our
study, with matching CFU burdens in C57BL/6 mice on day
1, the mutant was found to be attenuated with respect to
both lung CFU burden and immunopathology. No mortality
was observed out to 24 weeks. This finding underscores the
importance of assessing lung implantation CFU counts
when comparing the in vivo growth levels of M. tuberculosis
strains.
The immunological mechanisms by which the multiplication
of M. tuberculosis infection is contained vary between species.
In rabbit, guinea pig, monkey, and human tuberculosis, there is
caseous necrosis at the center of lesions (38), in which the
bacilli are rare and do not grow. In the mouse, there is no
caseous necrosis, and bacillary proliferation is controlled by
other means (1, 13). Necrotic human tuberculous lesions may
be hypoxic, and there is evidence suggesting that the lesions
are not vascularized (36) in other species, whereas in the
mouse, the lesions display abundant endothelial cells and vas-
cularization (2). Mouse macrophages can be induced by
gamma interferon (IFN-) or tumor necrosis factor alpha
(TNF-) to produce NO, which is lethal for tubercle bacilli.
The inhibition of NO production chemically or genetically
enhances bacillary proliferation in mice (5, 20). On the other
hand, the IFN--mediated induction of NO in rabbit, guinea
pig, and human monocytes/macrophages in vitro has been dif-
ficult to show (11, 25). Both mechanisms have lethal effects on
tubercle bacilli (4), and both mechanisms induce DosR and its
regulon (33, 34, 39). We found that crippling of this mechanism
did not enhance the ability of the bacilli to proliferate in mice,
which use the NO route of containment, or in guinea pigs and
rabbits, which may or may not use NO but certainly have
caseous necrosis and hypoxic granulomas (17, 38). Instead, an
inability to make a major adaptive response to hypoxia and NO
resulted in diminished levels of growth after high levels of NO,
TNF-, and IFN- are achieved in mice by week 2 (20) and the
onset of caseous necrosis in rabbit and guinea pig lungs (Fig. 2
and 5).
A limitation of our studies is the lack of cytokine data that
might contribute to a better understanding of the host immune
response to attenuated M. tuberculosis mutants. Previous stud-
ies of sigma factor sigH (13) and sigC (1) mutants, which
have an immunopathology phenotype characterized by signif-
icantly reduced inflammatory lesions in mice despite lung ba-
cillary loads comparable to those achieved by wild-type M.
tuberculosis, showed that this attenuated phenotype is associ-
ated with lower levels of TNF- and IFN- at certain time
points after infection. However, most cytokine analyses of at-
tenuated M. tuberculosis strains have been done using macro-
phage models (30) rather than animal organs, again revealing
reduced Th1-type immune responses. Given the attenuated
phenotype observed in our studies, we predict a similar pattern
of reduced levels of proinflammatory cytokines induced by the
dosR-S mutant.
Differences in the observed in vivo phenotypes of dosR-
deficient M. tuberculosis between our study and previously pub-
lished reports (21, 26) may also be explained by differences in
mutant generation. Parish et al. deleted the central 447 bp
between BalI sites of dosR without a drug resistance replace-
ment cassette (26), whereas our mutant lacks all but the most
distal 19 bp of dosR and contains a kanamycin-resistance cas-
sette. The kanamycin cassette inserted by Malhotra et al. (21)
left intact a region capable of encoding the first 145 N-terminal
amino acids of DosR and lacking only the 72-amino-acid C-
terminal domain. Although it is unclear why the two mutants
which lack most or all of the 3 coding region are attenuated,
it is possible that the deletion of this region disrupts the ex-
pression of dosS. Therefore, it would be worthwhile to test for
dosS expression in the other two mutants.
The phenotypes of M. tuberculosis strains have been charac-
terized primarily in terms of growth patterns and secondarily in
terms of murine host responses (10). Our dosR-S mutant
displayed a range of phenotypes in the various animal models
tested. Despite limited data, the dosR-S mutant appeared to
exhibit a persistence (per) phenotype, such as icl (24), in the
rabbit model, and a growth-in-vivo (giv) phenotype, such as
phoP (27), in the guinea pig model. In the mouse model,
when implantation doses of mutant and wild-type strains were
matched, the growth kinetics of the mutant were again consis-
tent with a giv phenotype. Therefore, depending on immune as
well as physicochemical factors stressing the organism, such as
NO and hypoxia, the dosR-S mutant exhibits varied pheno-
types either no different from or attenuated relative to that of
the wild type. These observations support the concept that
bacterial phenotypes are both dose and host dependent.
By testing M. tuberculosis mutants in different animal mod-
els, we more robustly assess gene function because of the
different conditions present in these models. Genes and their
products, which are potential drug or vaccine targets, may
function very differently in the intracellular compartments typ-
ically found in the mouse compared to the necrotic caseum in
rabbit or guinea pig lesions.
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